You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson’s disease
|
---|---|
Published in |
Frontiers in Aging Neuroscience, July 2014
|
DOI | 10.3389/fnagi.2014.00180 |
Pubmed ID | |
Authors |
Rakhee Krishna, Manal Ali, Ahmed A. Moustafa |
Abstract |
Prior studies report that monoamine oxidases inhibitors (MAO-I) when used as an adjunct to levodopa ameliorate motor symptoms in Parkinson's disease (PD), but this was not tested in relation to cognitive or psychiatric measures. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Mexico | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Canada | 1 | <1% |
Unknown | 124 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 26 | 21% |
Student > Ph. D. Student | 22 | 17% |
Student > Master | 12 | 10% |
Researcher | 9 | 7% |
Student > Doctoral Student | 7 | 6% |
Other | 20 | 16% |
Unknown | 30 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Psychology | 26 | 21% |
Medicine and Dentistry | 21 | 17% |
Neuroscience | 12 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 6% |
Biochemistry, Genetics and Molecular Biology | 6 | 5% |
Other | 17 | 13% |
Unknown | 36 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2014.
All research outputs
#15,690,772
of 23,316,003 outputs
Outputs from Frontiers in Aging Neuroscience
#3,707
of 4,944 outputs
Outputs of similar age
#134,052
of 230,072 outputs
Outputs of similar age from Frontiers in Aging Neuroscience
#53
of 80 outputs
Altmetric has tracked 23,316,003 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,944 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.2. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,072 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.